S&P 500   3,904.59 (-0.49%)
DOW   31,198.73 (-0.93%)
QQQ   291.04 (-0.03%)
AAPL   138.14 (-1.90%)
MSFT   255.24 (+0.46%)
FB   192.89 (+0.34%)
GOOGL   2,234.85 (-0.14%)
AMZN   2,171.19 (+1.35%)
TSLA   714.55 (+0.67%)
NVDA   174.45 (+2.99%)
BABA   87.47 (+0.18%)
NIO   16.50 (+4.23%)
AMD   99.31 (+3.15%)
CGC   5.80 (+3.76%)
MU   70.79 (-0.37%)
T   20.06 (-0.84%)
GE   75.53 (+0.44%)
F   12.84 (+0.47%)
DIS   103.97 (-0.32%)
AMC   12.97 (+1.65%)
PFE   49.63 (-1.53%)
PYPL   80.32 (+4.07%)
NFLX   182.56 (+3.03%)
S&P 500   3,904.59 (-0.49%)
DOW   31,198.73 (-0.93%)
QQQ   291.04 (-0.03%)
AAPL   138.14 (-1.90%)
MSFT   255.24 (+0.46%)
FB   192.89 (+0.34%)
GOOGL   2,234.85 (-0.14%)
AMZN   2,171.19 (+1.35%)
TSLA   714.55 (+0.67%)
NVDA   174.45 (+2.99%)
BABA   87.47 (+0.18%)
NIO   16.50 (+4.23%)
AMD   99.31 (+3.15%)
CGC   5.80 (+3.76%)
MU   70.79 (-0.37%)
T   20.06 (-0.84%)
GE   75.53 (+0.44%)
F   12.84 (+0.47%)
DIS   103.97 (-0.32%)
AMC   12.97 (+1.65%)
PFE   49.63 (-1.53%)
PYPL   80.32 (+4.07%)
NFLX   182.56 (+3.03%)
S&P 500   3,904.59 (-0.49%)
DOW   31,198.73 (-0.93%)
QQQ   291.04 (-0.03%)
AAPL   138.14 (-1.90%)
MSFT   255.24 (+0.46%)
FB   192.89 (+0.34%)
GOOGL   2,234.85 (-0.14%)
AMZN   2,171.19 (+1.35%)
TSLA   714.55 (+0.67%)
NVDA   174.45 (+2.99%)
BABA   87.47 (+0.18%)
NIO   16.50 (+4.23%)
AMD   99.31 (+3.15%)
CGC   5.80 (+3.76%)
MU   70.79 (-0.37%)
T   20.06 (-0.84%)
GE   75.53 (+0.44%)
F   12.84 (+0.47%)
DIS   103.97 (-0.32%)
AMC   12.97 (+1.65%)
PFE   49.63 (-1.53%)
PYPL   80.32 (+4.07%)
NFLX   182.56 (+3.03%)
S&P 500   3,904.59 (-0.49%)
DOW   31,198.73 (-0.93%)
QQQ   291.04 (-0.03%)
AAPL   138.14 (-1.90%)
MSFT   255.24 (+0.46%)
FB   192.89 (+0.34%)
GOOGL   2,234.85 (-0.14%)
AMZN   2,171.19 (+1.35%)
TSLA   714.55 (+0.67%)
NVDA   174.45 (+2.99%)
BABA   87.47 (+0.18%)
NIO   16.50 (+4.23%)
AMD   99.31 (+3.15%)
CGC   5.80 (+3.76%)
MU   70.79 (-0.37%)
T   20.06 (-0.84%)
GE   75.53 (+0.44%)
F   12.84 (+0.47%)
DIS   103.97 (-0.32%)
AMC   12.97 (+1.65%)
PFE   49.63 (-1.53%)
PYPL   80.32 (+4.07%)
NFLX   182.56 (+3.03%)
NYSE:USPH

U.S. Physical Therapy (USPH) Stock Forecast, Price & News

$104.97
-0.80 (-0.76%)
(As of 05/19/2022 11:20 AM ET)
Add
Compare
Today's Range
$104.01
$106.61
50-Day Range
$93.25
$108.61
52-Week Range
$84.43
$123.38
Volume
1,155 shs
Average Volume
82,755 shs
Market Capitalization
$1.36 billion
P/E Ratio
36.45
Dividend Yield
1.60%
Beta
1.23
30 days | 90 days | 365 days | Advanced Chart
Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy logo

About U.S. Physical Therapy

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Headlines

U.S. Physical Therapy goes ex dividend tomorrow
See More Headlines

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
5,500
Year Founded
N/A

Sales & Book Value

Annual Sales
$495.02 million
Cash Flow
$4.94 per share
Book Value
$23.26 per share

Profitability

Net Income
$40.83 million
Pretax Margin
14.36%

Debt

Price-To-Earnings

Miscellaneous

Free Float
12,744,000
Market Cap
$1.36 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/8 Dividend
3/11/2022
Dividend Payable
4/08/2022
Last Earnings
5/05/2022
Ex-Dividend for 6/14 Dividend
5/13/2022
Today
5/19/2022
Dividend Payable
6/14/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.52 out of 5 stars

Medical Sector

121st out of 1,418 stocks

Health Services Industry

3rd out of 19 stocks

Analyst Opinion: 2.5Community Rank: 3.9Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -













U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy
or view top-rated stocks.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for U.S. Physical Therapy
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings results on Thursday, May, 5th. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.02. The business earned $131.70 million during the quarter, compared to the consensus estimate of $128.57 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 14.77% and a net margin of 7.69%. U.S. Physical Therapy's revenue for the quarter was up 17.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.64 earnings per share.
View U.S. Physical Therapy's earnings history
.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, May 6th. Shareholders of record on Monday, May 16th will be paid a dividend of $0.41 per share on Tuesday, June 14th. This represents a $1.64 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend is Friday, May 13th.
View U.S. Physical Therapy's dividend history
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.60%. U.S. Physical Therapy has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of U.S. Physical Therapy is 56.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 44.44% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Thursday, March, 24th. The company provided EPS guidance of $3.250-$3.350 for the period, compared to the consensus estimate of $3.330. The company issued revenue guidance of -.

What price target have analysts set for USPH?

3 Wall Street analysts have issued 1-year price targets for U.S. Physical Therapy's shares. Their forecasts range from $120.00 to $123.00. On average, they expect U.S. Physical Therapy's share price to reach $121.50 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy
or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?
U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 58, Pay $2.02M) (LinkedIn Profile)
  • Mr. Carey P. Hendrickson, Chief Financial Officer (Age 60, Pay $902.32k)
  • Mr. Graham D. Reeve M.B.A., P.T., Chief Operating Officer - West (Age 58, Pay $1.28M) (LinkedIn Profile)
  • Mr. Eric Joseph Williams, Chief Operating Officer - East (Age 56, Pay $648.2k)
  • Mr. Richard S. Binstein, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Jon C. Bates, VP & Corp. Controller
  • Johnny J. Blanchard, Assistant Controller
What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.98%), Vanguard Group Inc. (7.14%), Copeland Capital Management LLC (4.03%), Eaton Vance Management (3.78%), State Street Corp (3.53%) and Boston Trust Walden Corp (3.47%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee and Mark J Brookner.
View institutional ownership trends for U.S. Physical Therapy
.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Ensign Peak Advisors Inc, Wasatch Advisors Inc., Renaissance Technologies LLC, Blair William & Co. IL, Goldman Sachs Group Inc., SG Americas Securities LLC, Aviva PLC, and Great Lakes Advisors LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
or view top insider-selling stocks.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was purchased by a variety of institutional investors in the last quarter, including Eaton Vance Management, Copeland Capital Management LLC, JPMorgan Chase & Co., Riverbridge Partners LLC, Royce & Associates LP, State Street Corp, BlackRock Inc., and Rhumbline Advisers. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, and Kathleen A Gilmartin.
View insider buying and selling activity for U.S. Physical Therapy
or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $105.73.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.37 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.88 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 5,500 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at (713) 297-7000, via email at [email protected], or via fax at 713-297-7090.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.